NASDAQ · Drug Manufacturers - Specialty & Generic

Indivior Pharmaceuticals, Inc. (INDV) Stock

$35.83 +1.07% NASDAQ: INDV Healthcare

Valuation

MetricValue
Price$35.83
Market Cap$4.47B
P/E Ratio12.72
P/B Ratio-21.77
P/S Ratio3.38
EPS (TTM)$1.64
52-Week High$42.81
52-Week Low$22.95
Dividend Yield22.50%

Financials & Margins

MetricValue
ROE-216.13%
ROA28.79%
ROCE141.92%
Gross Margin83.11%
Operating Margin33.31%
Net Margin26.65%
Debt/Equity-2.45
Current Ratio0.71

Annual Financials (USD)

Metric20212022202320242025
Revenue$791.0M$901.0M$1.1B$1.2B$1.2B
Operating Profit$213.0M$-81.0M$-156.0M$32.0M$265.0M
Net Profit$205.0M$-44.0M$-129.0M$2.0M$210.0M
EPS$1.31$-0.37$-0.91$0.02$1.64
Op Margin26.9%-9.0%-14.3%2.7%21.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.8B$1.8B$1.8B$1.3B$1.2B
Total Liabilities$1.6B$1.7B$2.0B$1.7B$1.3B
Cash$1.1B$778.0M$316.0M$319.0M$195.0M
Borrowings$286.0M$277.0M$283.0M$375.0M$351.0M

Latest News

Indivior’s Triple Russell 2000 Defensive Inclusion Could Be A Game Changer For Indivior Pharmaceuticals (INDV) Simply Wall St. · Jun 30, 2026 ACAD Stock Up as CHMP Backs Daybu for EU Approval in Rett Syndrome Zacks · Jun 29, 2026 Indivior Pharmaceuticals Inc. (INDV) is on the Move, Here's Why the Trend Could be Sustainable Zacks · Jun 29, 2026 Bull of the Day: Neurocrine Biosciences (NBIX) Zacks · Jun 29, 2026 IONS Out-Licenses ex-U.S. Rights for Rare Neurology Drug to Recordati Zacks · Jun 26, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$353.0M$-4.0M$-300.0M$36.0M$-27.0M
Investing Cash Flow$-48.0M$-227.0M$-148.0M$38.0M$-133.0M
Financing Cash Flow$-109.0M$-90.0M$-33.0M$-175.0M$-10.0M
Net Cash Flow$244.0M$-328.0M$-458.0M$3.0M$-124.0M
Free Cash Flow$319.0M$-9.0M$-353.0M$5.0M$-94.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.07
EV / EBITDA11.10
FCF Yield-2.46%
Quick Ratio0.66
Interest Coverage19.19
Return 1Y46.02%
Return 3Y53.27%
Return 5Y166.99%

Ownership

Insiders Held1.98%
Institutions Held108.89%
Institutions Float Held111.09%
Institutional HolderSharesReport Date
Blackrock Inc.18,542,2202026-03-31
Vanguard Portfolio Management LLC7,891,8192026-03-31
Oaktree Capital Management LP6,984,1022026-03-31
Vanguard Capital Management LLC5,586,5762026-03-31
State Street Corporation4,903,9932026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About Indivior Pharmaceuticals, Inc.

Indivior Pharmaceuticals, Inc. (INDV) stock trades at $35.83 with a market capitalization of $4.47B. The stock is valued at a price-to-earnings (P/E) ratio of 12.72, price-to-book of -21.77, price-to-sales of 3.38. Over the past 52 weeks the stock has ranged between $22.95 and $42.81, and currently trades 16.3% below its 52-week high. It pays a dividend yielding 22.50%.

On profitability, Indivior Pharmaceuticals, Inc. generates a return on equity (ROE) of -216.13%, return on capital employed of 141.92%, an operating margin of 33.31%, a net profit margin of 26.65%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.31 +0.33% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.67 +1.27%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides